Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates

14 Nov 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Viral Infections and Outbreaks Research
Share to Virology and Viral Diseases
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 17098273
DOI: 10.1016/j.virol.2006.10.026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primatesPMID 17098273Read ↗

Neurovirulence and Immunogenicity of Attenuated Recombinant Vesicular Stomatitis Viruses in Nonhuman PrimatesSemantic proximity Read ↗

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vectorSemantic proximity Read ↗

Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman PrimatesSemantic proximity Read ↗

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal modelsSemantic proximity Read ↗

Attenuation of Recombinant Vesicular Stomatitis Virus-Human Immunodeficiency Virus Type 1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in MiceSemantic proximity Read ↗

Nonhuman primate models of human viral infectionsSemantic proximity Read ↗

Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disordersSemantic proximity Read ↗

Recombinant Chimeric Western and Eastern Equine Encephalitis Viruses as Potential Vaccine CandidatesSemantic proximity Read ↗

Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector systemSemantic proximity Read ↗

Efficacy studies on a canarypox-rabies recombinant virusSemantic proximity Read ↗

Alphavirus vectors: development and potential therapeutic applicationsSemantic proximity Read ↗

Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based VaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.